To determine if we could experimentally overcome this deficient RRV-specific CD8+ T-cell response, we treated animals in the foot with an anti-IFNAR1 monoclonal antibody (mAb) or used Xcr1-Cre Ifnar1fl/fl mice to modulate the infection of antigen-presenting cells in the DLN. The gene discussed is CD8A; the disease is infection.